Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Avai Bio (AVAI) Return on Assets (2019 - 2023)

Avai Bio's Return on Assets history spans 4 years, with the latest figure at 11.54% for Q4 2023.

  • For Q4 2023, Return on Assets fell 1359.0% year-over-year to 11.54%; the TTM value through Dec 2023 reached 11.54%, down 1359.0%, while the annual FY2020 figure was 0.38%, N/A changed from the prior year.
  • Return on Assets for Q4 2023 was 11.54% at Avai Bio, down from 4.72% in the prior quarter.
  • Across five years, Return on Assets topped out at 46.71% in Q1 2019 and bottomed at 11.54% in Q4 2023.
  • The 4-year median for Return on Assets is 0.19% (2020), against an average of 2.23%.
  • The largest YoY upside for Return on Assets was 578bps in 2020 against a maximum downside of -4695bps in 2020.
  • A 4-year view of Return on Assets shows it stood at 5.01% in 2019, then skyrocketed by 115bps to 0.76% in 2020, then surged by 170bps to 2.06% in 2022, then plummeted by -661bps to 11.54% in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Return on Assets are 11.54% (Q4 2023), 4.72% (Q3 2023), and 3.06% (Q2 2023).